Imperial College London Featured PhD Programmes
University of West London Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University of Glasgow Featured PhD Programmes
University of Surrey Featured PhD Programmes
"pharmacology"×
10 miles

Pharmacy / Pharmaceutics (pharmacology) PhD Projects, Programs & Scholarships

We have 22 Pharmacy / Pharmaceutics (pharmacology) PhD Projects, Programs & Scholarships

  • "pharmacology" ×
  • Pharmacy / Pharmaceutics×
  • clear all
Order by 
Showing 1 to 10 of 22
  Pharmacology of soft nanomaterials: investigating nanoparticle-cell interaction
  Dr M Jones
Applications accepted all year round

Funding Type

PhD Type

Research into so-called ’soft’ or organic nanomaterials has been thriving with a wide variety of compositions being explored for pharmaceutical applications.
  Understanding the role of the lipid bilayer on receptor function
  Dr J Simms, Prof H Maddock
Application Deadline: 31 May 2019

Funding Type

PhD Type

Understanding how the binding of a single ligand influences the behaviour of a membrane protein target is of fundamental importance in drug discovery.
  Neuropeptide Research - PhD Opportunity at a World Class Institution
  Dr M Muttenthaler, Assoc Prof C Schroeder, Assoc Prof I Vetter
Application Deadline: 4 June 2019

Funding Type

PhD Type

We are seeking talented and highly motivated PhD candidates for the following multidisciplinary project. Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  Pharmacoepidemiological study to systematically investigate drug-related adverse events in older people
  Dr P Nishtala
Applications accepted all year round

Funding Type

PhD Type

A self-funded PhD studentship is available under the supervision of Dr Prasad Nishtala at the University of Bath. This is a collaborative project which will involve working with Dr Hamish Jamieson from the Big Data and Ageing Research Group at Christchurch, NZ.
  Predictive analytics to facilitate shared decision making in advanced cancers: The importance of communicating risk to advanced cancer patients
  Dr A Hopkins, Prof MJ Sorich
Applications accepted all year round

Funding Type

PhD Type

Project Title. Predictive analytics to facilitate shared decision making in advanced cancers. The importance of communicating risk to advanced cancer patients.
  Overcoming drug resistance in cancer using nano-encapsulated combination therapies
  Dr M Jones
Applications accepted all year round

Funding Type

PhD Type

Despite advances in cancer treatment, the development of drug resistance remains a major issue affecting long term patient survival.
  Therapeutic resolution of Myodysplastic Syndrome (MDS)
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Dr K Pors
Applications accepted all year round

Funding Type

PhD Type

Myelodysplastic syndromes (MDS) are the most common adult myeloid malignancy in the UK and it has been estimated that around 8,000 and 40,000 new cases are diagnosed each year in the UK and USA, respectively.
  Therapeutic resolution of pulmonary arterial hypertension (PAH) by natural products
  Research Group: Pharmacology and Experimental Therapeutics
  Dr T Nasim, Prof C Wright
Applications accepted all year round

Funding Type

PhD Type

Pulmonary arterial hypertension (PAH) is a devastating cardiovascular disorder which, if left untreated, leads to heart failure and death.
  How does the vascular matrix environment influence platelet activation?
  Dr S Calaminus
Application Deadline: 31 March 2020

Funding Type

PhD Type

The platelet is a blood cell that plays a key role in the prevention of bleeding. For platelets to form a clot or thrombus effectively, they must rearrange their actin cytoskeleton to withstand high shear stress from blood flow in the arteries.
  Identification of novel glucose-dependent alterations responsible for platelet dysfunction in Type 2 diabetes.
  Prof Tim Palmer, Dr F Rivero
Application Deadline: 31 March 2020

Funding Type

PhD Type

Type 2 diabetes mellitus (T2DM) is a growing global healthcare problem. Clinical findings suggest that more than 70% of patients with T2DM will die of cardiovascular diseases (CVDs) including heart attack and stroke.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.